Catalent's cold chain supply and distribution capabilities allow customers to utilize the company's packaging methods and logistical planning to protect the physical properties of biological products during transport and storage. The expansions will be implemented in all major areas of Catalent's cold chain storage and distribution, including 2° to 8° C and -80°C capabilities, in some cases more than tripling existing capacity for storage and distribution.
“Cold chain storage and distribution capabilities are in increasing demand throughout the industry and our customers are looking to Catalent to provide these services as a trusted partner who can ensure the integrity of their end-to-end cold chain needs,” says Frank Lis, vp and gm of Clinical Supply Services. “The steadily increasing number of biological products in development, particularly in prefilled syringes, is fueling the need for refrigerated storage and distribution.”
The enhanced global cold-chain expansion, combined with Catalent's offerings in comparator sourcing, clinical packaging, labeling, manufacturing, blinding, distribution, and warehousing enable it to better meet the needs of virtually any size clinical trial, with any drug, anywhere in the world.
“Due to the rapid increase in demand from our customers, these expansions were undertaken with future growth and development needs in mind. Today's investment will allow us to quickly scale-up and meet customer demands should future market growth dictate the need,” says Dan Gourley, director of global logistics at Catalent's Philadelphia, PA site. For more information, visit http://www.catalent.com/index.php#supply
Companies in this press-release
